Avalglucosidase Alfa
Records for this ingredient, by country (identity only).
ATC A16AB22 · 9 markets · 10 records
AU 2 records · 1 shown of 1
- 100 mg per mL / per unit basis not statedinjectionNEXVIAZYME avalglucosidase alfa powder for injection100mg vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 100 mg/10 mLinjectionNexviazyme
GB 1 records · 1 shown of 1
- 100 mg per mL / per unit basis not statedinjectionNexviadyme 100mg powder for concentrate for solution for infusion vials
CA 1 records · 1 shown of 1
- 100 mgpowderNexviazyme
SG 1 records · 1 shown of 1
- 100 mg/vial per mL / per unit basis not statedinjectionNEXVIAZYME POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
TW 1 records · 1 shown of 1
- 10 mg per mL / per unit basis not statedinjectionNEXVIAZYME 10 mg/mL Powder for Concentrate for Solution for Infusion貝瑞酶凍晶注射劑 10 mg/mL
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 100 mg per mL / per unit basis not statedinjectionNEXVIADYME 100 mg, poudre pour solution à diluer pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.